Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024
Pulse Biosciences (Nasdaq: PLSE), a company specializing in Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, has announced its plans to release third quarter 2024 financial results on Wednesday, October 30, 2024, after the market closes. The company will host a conference call at 1:30pm PT / 4:30pm ET on the same day to discuss the results.
Investors can participate in the call by dialing 1-877-407-0752 (domestic) or 1-201-389-0912 (international). Additionally, a live and recorded webcast of the event will be available on the company's investor relations website at http://investors.pulsebiosciences.com/.
Pulse Biosciences (Nasdaq: PLSE), una società specializzata nella tecnologia Nanosecond Pulsed Field Ablation™ (nsPFA™), ha annunciato i suoi piani per pubblicare i risultati finanziari del terzo trimestre 2024 il mercoledì 30 ottobre 2024, dopo la chiusura del mercato. L'azienda ospiterà una conference call alle 13:30 PT / 16:30 ET nello stesso giorno per discutere i risultati.
Gli investitori possono partecipare alla chiamata componendo il numero 1-877-407-0752 (nazionale) o 1-201-389-0912 (internazionale). Inoltre, un webcast dal vivo e registrato dell'evento sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda all'indirizzo http://investors.pulsebiosciences.com/.
Pulse Biosciences (Nasdaq: PLSE), una empresa especializada en la tecnología Nanosecond Pulsed Field Ablation™ (nsPFA™), ha anunciado sus planes para publicar los resultados financieros del tercer trimestre de 2024 el miércoles 30 de octubre de 2024, después del cierre del mercado. La compañía llevará a cabo una conferencia telefónica a la 1:30 p.m. PT / 4:30 p.m. ET el mismo día para discutir los resultados.
Los inversores pueden participar en la llamada marcando el 1-877-407-0752 (nacional) o el 1-201-389-0912 (internacional). Además, un webcast en vivo y grabado del evento estará disponible en el sitio web de relaciones con inversores de la empresa en http://investors.pulsebiosciences.com/.
Pulse Biosciences (Nasdaq: PLSE)는 나노초 펄스 필드 절제 기술 (nsPFA™)에 전문화된 회사로, 2024년 3분기 재무 결과를 2024년 10월 30일 수요일, 시장 마감 후 발표할 계획이라고 발표했습니다. 회사는 이날 오후 1시 30분 PT / 오후 4시 30분 ET에 결과를 논의하기 위한 컨퍼런스 콜을 개최합니다.
투자자는 1-877-407-0752 (국내) 또는 1-201-389-0912 (국제)로 전화하여 콜에 참여할 수 있습니다. 추가로, 이벤트의 실시간 및 녹화된 웹캐스트가 회사의 투자자 관계 웹사이트 http://investors.pulsebiosciences.com/에서 제공될 것입니다.
Pulse Biosciences (Nasdaq: PLSE), une entreprise spécialisée dans la technologie Nanosecond Pulsed Field Ablation™ (nsPFA™), a annoncé son intention de publier les résultats financiers du troisième trimestre 2024 le mercredi 30 octobre 2024, après la fermeture du marché. L'entreprise tiendra une conférence téléphonique à 13h30 PT / 16h30 ET le même jour pour discuter des résultats.
Les investisseurs peuvent participer à l'appel en composant le 1-877-407-0752 (national) ou le 1-201-389-0912 (international). De plus, un webinaire en direct et enregistré de l'événement sera disponible sur le site web des relations avec les investisseurs de l'entreprise à l'adresse http://investors.pulsebiosciences.com/.
Pulse Biosciences (Nasdaq: PLSE), ein Unternehmen, das sich auf die Nanosecond Pulsed Field Ablation™ (nsPFA™) Technologie spezialisiert hat, hat seine Pläne bekannt gegeben, die Finanzergebnisse für das dritte Quartal 2024 am Mittwoch, den 30. Oktober 2024, nach Marktschluss zu veröffentlichen. Das Unternehmen wird am selben Tag um 13:30 Uhr PT / 16:30 Uhr ET eine Konferenzschaltung abhalten, um die Ergebnisse zu besprechen.
Investoren können an der Telefonkonferenz teilnehmen, indem sie 1-877-407-0752 (inland) oder 1-201-389-0912 (international) wählen. Darüber hinaus wird ein Live- und aufgezeichneter Webcast der Veranstaltung auf der Investor-Relations-Website des Unternehmens unter http://investors.pulsebiosciences.com/ verfügbar sein.
- None.
- None.
Investors interested in listening to the conference call may do so by dialing 1-877-407-0752 for domestic callers or 1-201-389-0912 for international callers. A live and recorded webcast of the event will be available at http://investors.pulsebiosciences.com/.
About Pulse Biosciences®
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary CellFX® nsPFA™ technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. Pulse Biosciences is now headquartered in
Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241021098856/en/
Investors:
Pulse Biosciences, Inc.
Burke T. Barrett, President and CEO
IR@pulsebiosciences.com
Or
Gilmartin Group
Philip Trip Taylor
415.937.5406
philip@gilmartinir.com
Source: Pulse Biosciences, Inc.
FAQ
When will Pulse Biosciences (PLSE) report its Q3 2024 financial results?
What time is the Pulse Biosciences (PLSE) Q3 2024 earnings conference call?
How can investors access Pulse Biosciences' (PLSE) Q3 2024 earnings call?
What is Pulse Biosciences' (PLSE) primary technology focus?
